PT3137093T - Tratamento e prevenção da doença de alzheimer (da) - Google Patents
Tratamento e prevenção da doença de alzheimer (da)Info
- Publication number
- PT3137093T PT3137093T PT157200593T PT15720059T PT3137093T PT 3137093 T PT3137093 T PT 3137093T PT 157200593 T PT157200593 T PT 157200593T PT 15720059 T PT15720059 T PT 15720059T PT 3137093 T PT3137093 T PT 3137093T
- Authority
- PT
- Portugal
- Prior art keywords
- alzheimer
- disease
- prevention
- treatment
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14166354 | 2014-04-29 | ||
| EP14166355 | 2014-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3137093T true PT3137093T (pt) | 2017-12-19 |
Family
ID=53039896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT157200593T PT3137093T (pt) | 2014-04-29 | 2015-04-29 | Tratamento e prevenção da doença de alzheimer (da) |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10478454B2 (pt) |
| EP (2) | EP3137093B1 (pt) |
| JP (1) | JP6692755B2 (pt) |
| KR (1) | KR102388363B1 (pt) |
| CN (1) | CN106659738B (pt) |
| AU (1) | AU2015254663B2 (pt) |
| CA (1) | CA2946928C (pt) |
| CY (1) | CY1119674T1 (pt) |
| DK (1) | DK3137093T3 (pt) |
| ES (2) | ES2651537T3 (pt) |
| HR (1) | HRP20171896T1 (pt) |
| HU (1) | HUE037501T2 (pt) |
| LT (1) | LT3137093T (pt) |
| NO (1) | NO3137093T3 (pt) |
| PL (1) | PL3137093T3 (pt) |
| PT (1) | PT3137093T (pt) |
| SI (1) | SI3137093T1 (pt) |
| WO (1) | WO2015165966A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3137094T3 (pl) * | 2014-04-29 | 2023-03-13 | Advantage Therapeutics, Inc. | Leczenie i profilaktyka choroby alzheimera (ad) |
| ES2953381T3 (es) | 2014-04-29 | 2023-11-13 | Advantage Therapeutics Inc | Tratamiento y prevención de la enfermedad de Alzheimer (AD) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3440593A (en) | 1993-01-14 | 1994-08-15 | Nelson Arispe | Methods and compositions for blocking amyloid protein ion channels |
| TR200000455T2 (tr) * | 1997-08-21 | 2000-09-21 | P.N. Gerolymatos S.A. | Alzheimer hastalığının tedavisinde fankinonun kullanılması. |
| TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| AU2011234656B2 (en) * | 2010-03-29 | 2013-08-01 | Novartis Ag | Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant |
| PL3137094T3 (pl) * | 2014-04-29 | 2023-03-13 | Advantage Therapeutics, Inc. | Leczenie i profilaktyka choroby alzheimera (ad) |
| ES2953381T3 (es) * | 2014-04-29 | 2023-11-13 | Advantage Therapeutics Inc | Tratamiento y prevención de la enfermedad de Alzheimer (AD) |
-
2015
- 2015-04-29 WO PCT/EP2015/059339 patent/WO2015165966A1/en not_active Ceased
- 2015-04-29 US US15/307,082 patent/US10478454B2/en active Active
- 2015-04-29 PT PT157200593T patent/PT3137093T/pt unknown
- 2015-04-29 JP JP2016565267A patent/JP6692755B2/ja active Active
- 2015-04-29 CN CN201580029861.5A patent/CN106659738B/zh active Active
- 2015-04-29 DK DK15720059.3T patent/DK3137093T3/en active
- 2015-04-29 SI SI201530145T patent/SI3137093T1/en unknown
- 2015-04-29 HR HRP20171896TT patent/HRP20171896T1/hr unknown
- 2015-04-29 ES ES15720059.3T patent/ES2651537T3/es active Active
- 2015-04-29 KR KR1020167033332A patent/KR102388363B1/ko active Active
- 2015-04-29 ES ES17189527T patent/ES2824763T3/es active Active
- 2015-04-29 HU HUE15720059A patent/HUE037501T2/hu unknown
- 2015-04-29 LT LTEP15720059.3T patent/LT3137093T/lt unknown
- 2015-04-29 EP EP15720059.3A patent/EP3137093B1/en active Active
- 2015-04-29 EP EP17189527.9A patent/EP3269376B1/en active Active
- 2015-04-29 PL PL15720059T patent/PL3137093T3/pl unknown
- 2015-04-29 AU AU2015254663A patent/AU2015254663B2/en active Active
- 2015-04-29 CA CA2946928A patent/CA2946928C/en active Active
- 2015-04-29 NO NO15720059A patent/NO3137093T3/no unknown
-
2017
- 2017-12-13 CY CY20171101303T patent/CY1119674T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015254663B2 (en) | 2020-04-02 |
| EP3137093A1 (en) | 2017-03-08 |
| CN106659738B (zh) | 2021-02-09 |
| CY1119674T1 (el) | 2018-04-04 |
| AU2015254663A1 (en) | 2016-11-10 |
| US20170049812A1 (en) | 2017-02-23 |
| KR102388363B1 (ko) | 2022-04-19 |
| SI3137093T1 (en) | 2018-01-31 |
| PL3137093T3 (pl) | 2018-06-29 |
| EP3137093B1 (en) | 2017-09-13 |
| CA2946928A1 (en) | 2015-11-05 |
| KR20160145822A (ko) | 2016-12-20 |
| EP3269376A1 (en) | 2018-01-17 |
| HRP20171896T1 (hr) | 2018-02-23 |
| CA2946928C (en) | 2023-01-31 |
| JP6692755B2 (ja) | 2020-05-13 |
| WO2015165966A1 (en) | 2015-11-05 |
| JP2017518275A (ja) | 2017-07-06 |
| HUE037501T2 (hu) | 2018-08-28 |
| DK3137093T3 (en) | 2017-12-11 |
| LT3137093T (lt) | 2017-12-11 |
| ES2651537T3 (es) | 2018-01-29 |
| CN106659738A (zh) | 2017-05-10 |
| US10478454B2 (en) | 2019-11-19 |
| NO3137093T3 (pt) | 2018-02-10 |
| EP3269376B1 (en) | 2020-07-15 |
| ES2824763T3 (es) | 2021-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL247085A0 (en) | Methods for treating Alzheimer's disease | |
| IL276315A (en) | Donepezil preparations and a method for treating Alzheimer's disease | |
| ZA201605341B (en) | Methods of treating alzheimer's disease | |
| IL266047A (en) | Methods and preparations for the treatment of Fabry disease | |
| EP3182989A4 (en) | Methods and compositions for the prevention and treatment of disease | |
| IL248592A0 (en) | Treatment of Crohn's disease using delayed-release 6-mercaptofurin | |
| PL3137097T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
| IL248935A0 (en) | Diagnostic testing and treatment/prevention of Alzheimer's disease | |
| PT3458045T (pt) | Ebselen para uso no tratamento da doença de ménière | |
| PL3137094T3 (pl) | Leczenie i profilaktyka choroby alzheimera (ad) | |
| IL254252A0 (en) | History of Tetrahydrofuran-Oahe Aminohydrothiazine Usefulness in the Treatment of Alzheimer's Disease | |
| PL3352742T3 (pl) | Kompozycje zawierające triterpenoidy do leczenia choroby alzheimera i choroby parkinsona | |
| SG11201705889VA (en) | Prevention or Treatment of Uratic or Gouty Diseases | |
| HUE037501T2 (hu) | Alzheimer-kór (AD) kezelése és megelõzése | |
| IL251135A (en) | A method for the synthesis of hydroxy-triglycerides and their use for disease prevention and treatment | |
| ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
| GB201511453D0 (en) | Treatment of alzheimer's disease | |
| GB201621398D0 (en) | Treatment of emt-associated disease | |
| GB201504144D0 (en) | Treatment of Parkinson's disease | |
| AU2015904411A0 (en) | Compositions and methods for the treatment of Alzheimer's disease | |
| GB201518052D0 (en) | Parkinson's disease treatment | |
| GB201610906D0 (en) | Treatment of cardiovascular disease | |
| GB201504413D0 (en) | Treatment of disease | |
| HK1230506A1 (en) | Treatment of crohn's disease with delayed-release 6-mercaptopurine |